Evaluation of a Tetraplex Microsphere Assay for Bordetella pertussis Antibodies
Open Access
- 1 February 2006
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 13 (2) , 266-270
- https://doi.org/10.1128/cvi.13.2.266-270.2006
Abstract
To increase testing efficiency, a microsphere-based multianalyte immune detection (MAID) system was developed to measure serum immunoglobulin G (IgG) and IgA recognizing two Bordetella pertussis antigens, pertussis toxin (PT) and filamentous hemagglutinin antigen (FHA). The assay was performed as two separate duplexes. One duplex measured IgG to PT and FHA, and the other measured IgA to PT and FHA. The two duplexes were then combined and analyzed as a tetraplex. The MAID system and an in-house enzyme-linked immunosorbent assay (ELISA) system were used to evaluate 100 sera from blood donors and 220 consecutive sera submitted for B. pertussis antibody testing. For both the MAID and ELISA systems, antibody levels were defined as increased if greater than the blood donor group 95th percentile value. The qualitative concordance rates between MAID and ELISA results for the 220 consecutively submitted sera were as follows: PT IgG, 99%; PT IgA, 94%; FHA IgG, 93%; FHA IgA, 94%. The overall concordance rate was 95% (836 of 880 result sets). For 29 of 44 (66%) discordant result sets, the discordant MAID result was supported by the MAID and ELISA results for other B. pertussis antibodies. The MAID and in-house ELISA systems were also used to evaluate 20 sera previously tested for pertussis antibodies at a pertussis vaccine research laboratory; MAID results for all four analytes did not significantly differ from results obtained by the research laboratory. These findings show that antibodies to B. pertussis antigens can be measured easily and accurately using a tetraplex microsphere system.Keywords
This publication has 21 references indexed in Scilit:
- New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis InitiativeClinical Infectious Diseases, 2004
- Prevalence of Antibody toBordetella pertussisAntigens in Serum Specimens Obtained from 1793 Adolescents and AdultsClinical Infectious Diseases, 2004
- Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT StudyThe Journal of Infectious Diseases, 2004
- Serologic Response and Antibody‐Titer Decay in Adults with PertussisClinical Infectious Diseases, 2004
- Comparison of a Multiplexed Fluorescent Covalent Microsphere Immunoassay and an Enzyme-Linked Immunosorbent Assay for Measurement of Human Immunoglobulin G Antibodies to Anthrax ToxinsClinical and Vaccine Immunology, 2004
- Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex AssayClinical and Vaccine Immunology, 2003
- Antibody Responses to Bordetella pertussis Antigens and Clinical Correlations in Elderly Community ResidentsClinical Infectious Diseases, 2000
- Frequency of Unrecognized Bordetella pertussis Infections in AdultsClinical Infectious Diseases, 1995
- Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussisThe Pediatric Infectious Disease Journal, 1995
- Pertussis in Massachusetts, 1981-1991: Incidence, Serologic Diagnosis, and Vaccine EffectivenessThe Journal of Infectious Diseases, 1994